News | Cardiovascular Business | August 02, 2023

Dr. Doria A. Scortichini MD, FACC Joins Auburn Heart Institute

Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists 

Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists

Doria Scortichini, MD FACC 


August 2, 2023 —   Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn Community Hospital.  Dr. Scortichini is a cardiology specialist in Geneva, New York and has over 40 years of experience in cardiovascular diseases.  Dr. Scortichini graduated from Albany Medical College of Union University and completed her residency and cardiology fellowship at Bronx Municipal Hospital and Albert Einstein College of Medicine Hospital followed by a fellowship in interventional cardiology at the Montreal Heart Institute. Dr. Scortichini is board certified in Internal Medicine and Cardiovascular Diseases. 

Dr. Scortichini will continue to provide the same high level cardiac care as part of the Auburn Heart Institute located not far from her current practice. Dr. Scortichini is accepting new patients and we invite current patients to take the short drive to Auburn in order to continue to receive the outstanding care you have come to rely upon from Dr. Scortichini. Patients can begin scheduling appointments immediately by calling the number below. 

"We are thrilled to have someone of Dr. Scortichini' s experience join the Auburn Heart Institute and Auburn Community Hospital. Dr. Scortichini is recognized by her patients and colleagues throughout the Finger Lakes region as a very respected heart specialist who has been diagnosing, preventing, and treating heart disease in our region for years and will be a tremendous asset as we build the Auburn Heart Institute, and care for patients throughout the Finger Lakes region," stated Dr. Ronald Kirshner, Chair & Medical Director of the Auburn Heart Institute. 

"I am excited to join the team at the Auburn Heart Institute, and to be part of Auburn Hospital and this community.  Dr. Kirshner and Scott Berlucchi are building a first-class comprehensive cardiology center, and I look forward to being part of this patient centered endeavor.  The Heart Institute is committed to bringing in a very talented multidisciplinary team.  These physicians are currently treating patients as we simultaneously begin building the new Heart Institute.  I am impressed with the investments Auburn Community Hospital's leadership has made in new technology and talent to care for all the patients in our region," stated Dr. Scortichini.   

For more information: https://www.auburnhospital.org/ 


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now